Table 2. Clinical characteristics.
| Subject | Control group (n=62) | Treatment group (n=64) |
|---|---|---|
| Type of ACS (%) | ||
| NSTEMI | 10 (16.1) | 11 (17.2) |
| STEMI | 12 (19.4) | 17 (26.6) |
| UA | 40 (64.5) | 36 (56.2) |
| Culprit vessel (%) | ||
| LAD | 25 (40.3) | 27 (42.2) |
| RCA | 16 (25.8) | 19 (29.7) |
| LCX | 21 (33.9) | 18 (28.1) |
| LVEF (%) | 50.7±7.3 | 51.2±7.9 |
| Hypertension (%) | 45 (72.6) | 47 (73.4) |
NSTEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; UA, unstable angina pectoris; LAD, left anterior descending artery; RCA, right coronary artery; LCX, left circumflex branch; LVEF, left ventricular ejection fraction.